Stock Analysis Report

Header cover image

Executive Summary

Cigna Corporation provides insurance and related products and services. More Details

Snowflake Analysis

Undervalued with solid track record and pays a dividend.

Similar Companies

Share Price & News

How has Cigna's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: CI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: CI's weekly volatility (7%) has been stable over the past year.

Market Performance

7 Day Return




US Healthcare


US Market

1 Year Return




US Healthcare


US Market

Return vs Industry: CI underperformed the US Healthcare industry which returned 13.5% over the past year.

Return vs Market: CI underperformed the US Market which returned 21% over the past year.

Shareholder returns

7 Day-0.9%-2.1%-0.9%
30 Day8.2%5.9%3.0%
90 Day23.0%12.4%11.5%
1 Year3.0%3.0%15.6%14.2%22.3%19.6%
3 Year-0.5%-0.6%32.6%27.0%45.3%35.7%
5 Year58.9%58.7%92.2%78.4%124.8%99.9%

Long-Term Price Volatility Vs. Market

How volatile is Cigna's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is Cigna undervalued compared to its fair value and its price relative to the market?


Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: CI ($218.9) is trading below our estimate of fair value ($541.57)

Significantly Below Fair Value: CI is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: CI is good value based on its PE Ratio (15.2x) compared to the US Healthcare industry average (29.8x).

PE vs Market: CI is good value based on its PE Ratio (15.2x) compared to the US market (21.3x).

Price to Earnings Growth Ratio

PEG Ratio: CI is poor value based on its PEG Ratio (1.7x)

Price to Book Ratio

PB vs Industry: CI is good value based on its PB Ratio (1.7x) compared to the US Healthcare industry average (3.6x).

Next Steps

Future Growth

How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CI's forecast earnings growth (9.1% per year) is above the savings rate (2%).

Earnings vs Market: CI's earnings (9.1% per year) are forecast to grow slower than the US market (21.6% per year).

High Growth Earnings: CI's earnings are forecast to grow, but not significantly.

Revenue vs Market: CI's revenue (5.1% per year) is forecast to grow slower than the US market (10.2% per year).

High Growth Revenue: CI's revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CI's Return on Equity is forecast to be low in 3 years time (15.9%).

Next Steps

Past Performance

How has Cigna performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CI has high quality earnings.

Growing Profit Margin: CI's current net profit margins (3.4%) are higher than last year (3.3%).

Past Earnings Growth Analysis

Earnings Trend: CI's earnings have grown significantly by 23.3% per year over the past 5 years.

Accelerating Growth: CI's earnings growth over the past year (23.8%) exceeds its 5-year average (23.3% per year).

Earnings vs Industry: CI earnings growth over the past year (23.8%) exceeded the Healthcare industry 21.4%.

Return on Equity

High ROE: CI's Return on Equity (11.1%) is considered low.

Next Steps

Financial Health

How is Cigna's financial position?

Financial Position Analysis

Short Term Liabilities: CI's short term assets ($34.6B) do not cover its short term liabilities ($43.9B).

Long Term Liabilities: CI's short term assets ($34.6B) do not cover its long term liabilities ($68.1B).

Debt to Equity History and Analysis

Debt Level: CI's debt to equity ratio (74.7%) is considered high.

Reducing Debt: CI's debt to equity ratio has increased from 43.9% to 74.7% over the past 5 years.

Debt Coverage: CI's debt is well covered by operating cash flow (24.6%).

Interest Coverage: CI's interest payments on its debt are well covered by EBIT (6.5x coverage).

Balance Sheet

Next Steps


What is Cigna current dividend yield, its reliability and sustainability?


Current Dividend Yield

Upcoming Dividend Payment

Dividend Yield vs Market

Notable Dividend: CI's dividend (1.83%) is higher than the bottom 25% of dividend payers in the US market (1.38%).

High Dividend: CI's dividend (1.83%) is low compared to the top 25% of dividend payers in the US market (3.84%).

Stability and Growth of Payments

Stable Dividend: CI's dividends per share have been stable in the past 10 years.

Growing Dividend: CI's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (0.3%), CI's dividend payments are thoroughly covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CI's dividend in 3 years as they are not forecast to pay a notable one for the US market.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


David Cordani (55 yo)





Mr. David Michael Cordani has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and June 2008 respectively and has been its Director since October 2009. Mr. Cordan...

CEO Compensation Analysis

Compensation vs Market: David's total compensation ($USD19.30M) is above average for companies of similar size in the US market ($USD10.54M).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

Leadership Team

David Cordani
$ 100.0m
Nicole Jones
Executive VP & General Counsel9.58yrsUS$4.56m0.0091%
$ 7.2m
Matthew Manders
President of Government & Solutions2.17yrsUS$6.20m0.013%
$ 10.1m
Eric Palmer
President & COO of Evernorthno dataUS$6.14m0.0074%
$ 5.9m
Timothy Wentworth
Chief Executive Officer of Evernorth2.08yrsUS$23.54m0.021%
$ 16.7m
Brian Evanko
Executive VP & CFOno datano data0.0043%
$ 3.4m
Mary Terese Hoeltzel
Senior VP of Tax & Chief Accounting Officer11.5yrsno data0.0019%
$ 1.5m
Mark Boxer
Executive VP & Global Chief Information Officer9.75yrsno data0.014%
$ 10.9m
Noelle Eder
Executive VP & Global Chief Information Officer0.33yrno data0.0016%
$ 1.3m
William McDowell
Vice President of Investor Relationsno datano datano data
Kristen Lauria
Global Chief Marketing Officer & Executive VP0.83yrno data0.00036%
$ 284.7k
John Murabito
Executive Vice President of Human Resources & Services17.42yrsUS$3.51m0.013%
$ 10.4m


Average Tenure


Average Age

Experienced Management: CI's management team is seasoned and experienced (9.6 years average tenure).

Board Members

David Cordani
$ 100.0m
H. Hanway
Chairman Emeritusno dataUS$18.82mno data
Donna Zarcone
Independent Director15.92yrsUS$341.39k0.0069%
$ 5.4m
Eric Foss
Independent Director9.5yrsUS$310.37k0.0089%
$ 7.0m
William Roper
Independent Director2.08yrsUS$335.37k0.0014%
$ 1.1m
Eric Wiseman
Independent Director13.75yrsUS$317.15k0.0054%
$ 4.2m
Isaiah Harris
Independent Chairman of the Board11.08yrsUS$575.35k0.0053%
$ 4.2m
Kathleen Mazzarella
Independent Director2.08yrsUS$310.37k0.00065%
$ 514.0k
William DeLaney
Independent Director2.08yrsUS$310.37k0.0056%
$ 4.4m
John Partridge
Independent Director12yrsUS$335.37k0.0079%
$ 6.2m
Mark McClellan
Independent Director2.08yrsUS$310.37k0.00065%
$ 514.0k
Elder Granger
Independent Director2.08yrsUS$310.37k0.00079%
$ 624.7k


Average Tenure


Average Age

Experienced Board: CI's board of directors are considered experienced (9.5 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Cigna Corporation's company bio, employee growth, exchange listings and data sources

Key Information

  • Name: Cigna Corporation
  • Ticker: CI
  • Exchange: NYSE
  • Founded: 1792
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$79.081b
  • Shares outstanding: 361.27m
  • Website: https://www.cigna.com

Number of Employees


  • Cigna Corporation
  • 900 Cottage Grove Road
  • Bloomfield
  • Connecticut
  • 6002
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CINYSE (New York Stock Exchange)YesCommon StockUSUSDApr 1982
CGNDB (Deutsche Boerse AG)YesCommon StockDEEURApr 1982
CI *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNApr 1982
CGNXTRA (XETRA Trading Platform)YesCommon StockDEEURApr 1982
CIGNWBAG (Wiener Boerse AG)YesCommon StockATEURApr 1982
CGNETLX (Eurotlx)YesCommon StockITEURApr 1982
C1IC34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 24 REPR 1 SHS UNSPONBRBRLJan 2020


Cigna Corporation provides insurance and related products and services. It operates through Health Services, Integrated Medical, International Markets, and Group Disability and Other segments. The Health S...

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/15 23:18
End of Day Share Price2021/01/15 00:00
Annual Earnings2019/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.